You are herePharma- und Produktvigilanz, Sicherheit medizinischer Technologien
Pharma- und Produktvigilanz, Sicherheit medizinischer Technologien
Tags
ASHP - American Society of Health-System Pharmacists - Health-System Pharmacy News
BfArM - Bundesinstitut für Arzneimittel und Medizinprodukte
- Rote-Hand-Brief zu Aclasta® (Wirkstoff: Zoledronsäure): Berichte über Nierenfunktionsstörungen und Nierenversagen
- Ciprofloxacin-haltige Generika: Übertragung der Ergebnisse des Harmonisierungsverfahrens für den Originator auf die Generika
- Info-Brief zu Protopic® (Wirkstoff: Tacrolimus): Empfehlungen zur Kontrolle der Erhaltungstherapie
- Info-Brief zu Protopic® (Wirkstoff: Tacrolismus): Empfehlungen zur Kontrolle der Erhaltungstherapie
- Ergebnisprotokoll der 65. Routinesitzung vom 12.11.2009
Eurosurveillance
- Ongoing rubella outbreak among adolescents in Salaj, Romania, September 2011-January 2012
- Isolation of NDM-1-producing Klebsiella pnemoniae in Ireland, July 2011
- NDM-1 producing Acinetobacter baumannii isolated from a patient repatriated to the Czech Republic from Egypt, July 2011
- Microbiological and molecular characteristics of carbapenemase-producing Klebsiella pneumoniae endemic in a tertiary Greek hospital during 2004-2010
- Emergence and outbreak of carbapenemase-producing KPC-3 Klebsiella pneumoniae in Spain, September 2009 to February 2010: control measures
FDA What's New: Drugs
- Comunicado de la FDA sobre la seguridad de los medicamentos: Nuevo factor de riesgo para la leucoencefalopatía multifocal progresiva (PML por sus siglas en inglés) relacionado con Tysabri (natalizumab)
- New and Generic Drug Approvals
- Comunicado de la FDA sobre la seguridad de los medicamentos: La diarrea asociada con Clostridum difficile puede estar relacionada con los medicamentos contra la acidez estomacal denominados inhibidores de la bomba de protones (PPIs por sus siglas en inglé
- Generic Drugs: Information for Industry
- Newly Added Guidance Documents
FDA What's New: Vaccines, Blood & Biologics
MedEffect Canada - Recent Advisories Warnings and Recalls
- Health Canada Reminds Canadians to Check Medical Device Clocks after Switch to Daylight Savings Time [2010-03-12]
- Fentanyl Transdermal Systems - New Changes to the Dose Conversion Guidelines - Janssen-Ortho Inc., Cobalt Pharmaceuticals Inc., Teva Canada Limited, Ranbaxy Pharmaceuticals Canada Inc., ratiopharm inc., Sandoz Canada Inc. and Pharmascience Inc. For Health
- Unapproved Health Product, "POWER-MAX" May Pose Serious Health Risks [2010-03-08]
- Foreign Product Alert - Tian Yang Xu Huo Oral Ulcer Capsule [2010-03-01]
- Foreign Product Alert - STRO Emperor Capsules [2010-03-01]
Medicines and Healthcare products Regulatory Agency (MHRA) - Drug Safety Update
Medsafe New Zealand - Prescriber Update Articles
MedWatch: The FDA Safety Information and Adverse Event Reporting Program
- Infants’ TYLENOL Oral Suspension, 1 oz. Grape: Recall - Dosing System Complaints
- Spinbrush Powered Toothbrush by Arm and Hammer or Crest: Safety Communication - Choking Hazard and Serious Injuries
- Avastin (bevacizumab): Counterfeit Product - FDA Issues Letters to 19 Medical Practices
- Salter Labs 7600 Bubble Humidifier Used with Supplemental Oxygen Therapy: Class I Recall - Humidifier Lids Fail to Pop Off at the Intended Pressure
- RegenArouse: Recall - Undeclared Drug Ingredient
Deutsch
English